Hit ‘em Where It Hurts: Gram-Negative Bacterial Lipopolysaccharide as a Vaccine Target
Microbiology and Molecular Biology Reviews · 26.09.2023 · 87 (3)
DOI: 10.1128/mmbr.00045-22 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Microbiology and Molecular Biology Reviews, erschienen am 26.09.2023. Verfasst von Alan S Cross. Beteiligte Einrichtung: Center for Vaccine Development and Global Health, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Anti-Infective Agents, Vaccines, Gram-Negative Bacterial Infections. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 336 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, Affinivax, Inc/GSK, HHS | NIH | National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Infections with antimicrobial-resistant (AMR) bacteria pose an increasing threat to the ability to perform surgical procedures, organ transplantation, and treat cancer among many other medical conditions. There are few new antimicrobials in the development pipeline.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Vaccine Development and Global Health, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
ORCID-Profile: Alan S Cross
Förderung
- NIAID NIH HHS
- Affinivax, Inc/GSK
- HHS | NIH | National Institute of Allergy and Infectious Diseases
Zitieren
APA
Cross, A. S. (2023). Hit ‘em Where It Hurts: Gram-Negative Bacterial Lipopolysaccharide as a Vaccine Target. Microbiology and Molecular Biology Reviews, 87(3). https://doi.org/10.1128/mmbr.00045-22
Vancouver
Cross AS. Hit ‘em Where It Hurts: Gram-Negative Bacterial Lipopolysaccharide as a Vaccine Target. Microbiology and Molecular Biology Reviews. 2023;87(3). doi:10.1128/mmbr.00045-22
BibTeX
@article{Cross2023,
author = {Cross, Alan S},
title = {Hit ‘em Where It Hurts: Gram-Negative Bacterial Lipopolysaccharide as a Vaccine Target},
journal = {Microbiology and Molecular Biology Reviews},
year = {2023},
volume = {87},
number = {3},
doi = {10.1128/mmbr.00045-22}
}
EUVIMED